COMPARATIVE STUDY OF VITAMIN B12 DEFICIENCY ASSOCIATED WITH METFORMIN AND METFORMIN IN COMBINATION WITH DPP-4 INHIBITORS IN A TERTIARY CARE HOSPITAL
DOI:
https://doi.org/10.22159/ijpps.2023v15i10.47818Keywords:
Type 2 diabetes mellitus, Metformin, DPP-4 inhibitors, Vitamin B12Abstract
Objective: To estimate the prevalence of vitamin B12 deficiency in type 2 diabetes mellitus patients receiving metformin and metformin in combination with DPP-4 inhibitors. To evaluate the vitamin B12 levels induced by long-term metformin usage.
Methods: It is a retrospective, comparative study of 6 mo, conducted at Shadan Institute of Medical Sciences, Hyderabad. 300 diabetic patients of age group between 30-85 y of either gender were divided into Group-A, receiving metformin and Group-B, receiving metformin+DPP-4 inhibitors. Ethics committee approval was o btained. The baseline and after 6 mo values of Vitamin B12 were noted and analyzed by using SPSS software.
Results: The majority of the patients were from the age group of 56-65 y (n=42, 28%) in Group-A and 46-55 y (n=61, 40.7%) in Group B. Male predominance was observed in both groups (n=81, 54% and n=76, 50.7%). Duration of Diabetes mellitus was ≤5 y in both groups (n=87, 58% and n=112, 74.7%). Vitamin B12 mean values for Group-A (Baseline-478.61, After 6 mo-195.94) and Group-B (Baseline-527.82, After 6 mo-299.05) were obtained. Mean reduction with a statistical significance in both study groups was observed (Group-A-282.66 and Group-B-228.77). Most of the patients showed numbness (14%) in Group-A and general weakness (7.3%) in Group B, respectively.
Conclusion: Type 2 diabetic patients who were on metformin therapy only have a prevalence of vitamin B12 deficiency compared to Metformin in combination with DPP-4 inhibitors receiving patients.
Downloads
References
International Diabetes Federation. IDF diabetes atlas. 10th ed Brussels. Belgium; 2021. Available from: https://www.diabetesatlas.org.
Sen A. Health: perception versus observation. BMJ. 2002 Apr 13;324(7342):860-1. doi: 10.1136/bmj.324.7342.860, PMID 11950717, PMCID PMC1122815.
Yajnik CS, Deshpande SS, Lubree HG, Naik SS, Bhat DS, Uradey BS. Vitamin B12 deficiency and hyperhomocysteinemia in rural and urban Indians. J Assoc Physicians India. 2006 Oct;54:775-82, PMID 17214273.
Bommineni SR, Shravani P, Shyam J, Alekhya M, Srikanth B. A comparative study of efficacy on glycemic control by glimepiride versus teneligliptin as an add on to metformin therapy in type 2 diabetes mellitus patients. Int J Curr Pharm Sci. 2022 Mar;14:26-30. doi: 10.22159/ijcpr.2022v14i2.1939.
Kapil U, Bhadoria AS. Prevalence of Folate, ferritin and cobalamin deficiencies amongst adolescent in India. J Family Med Prim Care. 2014 Jul;3(3):247-9. doi: 10.4103/2249-4863.141619, PMID 25374863, PMCID PMC4209681.
Liu Q, Li S, Quan H, Li J. Vitamin B12 status in metformin treated patients: systematic review. Plos One. 2014;9(6):e100379. doi: 10.1371/journal.pone.0100379. PMID 24959880.
Kibirige D, Mwebaze R. Vitamin B12 deficiency among patients with diabetes mellitus: is routine screening and supplementation justified? J Diabetes Metab Disord. 2013 May 7;12(1):17. doi: 10.1186/2251-6581-12-17, PMID 23651730, PMCID PMC3649932.
Mazokopakis EE, Starakis IK. Recommendations for diagnosis and management of metformin-induced vitamin B12 (Cbl) deficiency. Diabetes Res Clin Pract. 2012 Sep;97(3):359-67. doi: 10.1016/j.diabres.2012.06.001, PMID 22770998.
LS, DY. A study on serum vitamin B12 levels in type 2 diabetic women and its correlation with metformin therapy. Int J Med Res Rev. 2019;7(4):332-8. doi: 10.17511/ijmrr.2019.i04.12.
Raizada N, Jyotsna VP, Sreenivas V, Tandon N. Serum vitamin B12 levels in type 2 diabetes patients on metformin compared to those never on metformin: a cross-sectional study. Indian J Endocrinol Metab. 2017 May-Jun;21(3):424-8. doi: 10.4103/ijem.IJEM_529_16. PMID 28553599, PMCID PMC5434727.
Alhaji JH. Vitamin B12 deficiency in patients with diabetes on metformin: Arab countries. Nutrients. 2022 May 13;14(10):2046. doi: 10.3390/nu14102046, PMID 35631186, PMCID PMC9144422.
Elhadd T, Ponirakis G, Dabbous Z, Siddique M, Chinnaiyan S, Malik RA. Metformin use is not associated with B12 deficiency or neuropathy in patients with type 2 diabetes mellitus in Qatar. Front Endocrinol (Lausanne). 2018 May 25;9:248. doi: 10.3389/fendo.2018.00248, PMID 29887831, PMCID PMC5980977.
Agarwal P, Mital P, Meena VK, Mital P, Nawal CL, Goyal L. A comparative study of levels of vitamin B12 in patients of type 2 diabetes mellitus on metformin and not on metformin at tertiary care center. Int J Adv Med. 2016 Aug 4;3(3):759-63. doi: 10.18203/2349-3933.ijam20162531.
Yousef Khan F, Yousif AB, Suliman A, Saleh AO, Magdi M, Alshurafa A. Association of vitamin B12 deficiency with metformin use in patients with type 2 diabetes treated in the largest tertiary care hospital in qatar. Qatar Med J. 2021 Sep 9;2021(2):39. doi: 10.5339/qmj.2021.39, PMID 34540601, PMCID PMC8428509.
Damiao CP, Rodrigues AO, Pinheiro MF, Cruz RA Filho, Cardoso GP, Taboada GF. Prevalence of vitamin B12 deficiency in type 2 diabetic patients using metformin: a cross-sectional study. Sao Paulo Med J. 2016 Nov-Dec;134(6):473-9. doi: 10.1590/1516-3180.2015.01382111, PMID 28076635.
Kotli N, Sourabh S. Study to assess the etiology of vitamin B12 deficiency in patients of north Karnataka. MIJOMED. 2019;12(3):100-5. doi: 10.26611/10211238.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Nabiha Subhani Misbah, Syeda Ayesha Siddiqua, Juwaria Masood, NASER ASHRAF TADVI, Arooba Fatima
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.